Top Markets
#1 Derive Derive +31.23%
#2 Cross Cross +14.51%
#3 Geodnet Geodnet +13.18%
#4 Gama Token Gama Token +9.16%
#5 Steakhouse ETH Morpho Vault Steakhouse ETH Morpho Vault +7.47%
#6 Talus Network Talus Network +7.24%
#7 Codatta Codatta +6.12%
#8 Humanity Humanity +5.46%
#9 Based Based +5.42%
#10 龙虾 (Lobster) 龙虾 (Lobster) +5.22%
Coin of the day
Derive Derive
設定
言語
日本
通貨
USD
テーマ
Israel Canada Hotels Ltd Israel Canada Hotels Ltd

Israel Canada Hotels Ltd

ICHO
株式のランク #36100
Israel Canada Hotels Ltd, operating through its various subsidiaries, is... Israel Canada Hotels Ltd, operating through its various subsidiaries, is globally involved in the creation, production, and distribution of patented ultrasound technology. These advanced systems are instrumental in assessing bone strength and density, alongside tracking calcium loss, especially for diagnosing osteoporosis in both adults and children. Beyond its medical device activities, the company also engages in the development of oral pharmaceuticals. Incorporated in 2004 and based in Tel Aviv, Israel, the entity, which was previously known as Dna Group (T.R.) Ltd, is set to formally adopt the name Israel Canada Hotels Ltd in November 2025.
株価
$0.33775087
最終同期: 2026-08-14
時価総額
$3.03M
変化（1日）
1.46%
変化（1年）
8.47%
国
IL
取引 Israel Canada Hotels Ltd (ICHO)

カテゴリー

Consumer Cyclical
Israel Canada Hotels Ltd（ICHO）の利益
2026 時点の利益 TTM: 0
Israel Canada Hotels Ltd の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Israel Canada Hotels Ltd の利益の推移（2026 〜 2026）
各年末の利益
年 利益 変化
提供された日付のデータは十分ではありません。
同業他社の利益
企業 利益 利益の差 国
Marriott International, Inc. Marriott International, Inc.
Marriott International, Inc.
MAR.US
$3.48B -
US
Hilton Worldwide Holdings Inc. Hilton Worldwide Holdings Inc.
Hilton Worldwide Holdings Inc.
HLT.US
$2.23B -
US
InterContinental Hotels Group PLC InterContinental Hotels Group PLC
InterContinental Hotels Group PLC
IHG.L
- -
GB
Hyatt Hotels Corporation Hyatt Hotels Corporation
Hyatt Hotels Corporation
H.US
$230.00M -
US
Accor S.A. Accor S.A.
Accor S.A.
AC.PA
$612.06M -
FR